Related Experiment Video
Updated: May 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between frequency of drinking alcohol and chronic kidney disease in men
Yayoi Funakoshi1, Hisamitsu Omori, Ayumi Onoue
1Department of Public Health, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjou, Kumamoto, Japan.
Insights
This study found that drinking alcohol, even daily, was associated with a lower risk of chronic kidney disease (CKD) in Japanese men. These findings suggest a potential protective effect of alcohol consumption against CKD progression.
Area of Science:
- Nephrology
- Epidemiology
- Public Health
Background:
- Chronic kidney disease (CKD) poses a significant global health challenge.
- Epidemiological data on alcohol consumption and CKD in Japan are limited.
Purpose of the Study:
- To investigate the association between the frequency of alcohol consumption and CKD in Japanese men.
- To provide insights into the relationship between drinking habits and kidney health within a Japanese population.
Main Methods:
- A cross-sectional study involving 9,196 Japanese men aged 57.9 ± 5.1 years.
- CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m².
- Alcohol consumption frequency was categorized into five groups: non-drinkers, 1-2, 3-4, 5-6 times/week, and everyday drinkers.
Main Results:
- A significant inverse association was observed between alcohol drinking frequency and CKD.
- Compared to non-drinkers, odds ratios for CKD were 0.76, 0.74, 0.79, and 0.60 for increasing frequencies of alcohol intake.
- A significant inverse trend (p=0.001) indicated lower CKD risk with higher drinking frequency.
Conclusions:
- An inverse association exists between the frequency of alcohol consumption and CKD in apparently healthy Japanese men.
- Higher frequency of alcohol intake was linked to a reduced risk of developing CKD.
Objectives:
Chronic kidney disease (CKD) is a major public health problem. Epidemiological studies of the relationship between alcohol intake and CKD are scarce in Japan. This cross-sectional study aims to investigate the relationship between frequency of drinking alcohol and CKD in Japanese men.
Methods:
The subjects were 9,196 men (mean ± standard deviation age, 57.9 ± 5.1 years) who underwent a health check-up. CKD was defined as estimated glomerular filtration rate <60 mL/min/1.73 m(2). Frequency of alcohol drinking was obtained from questionnaire and divided into five categories: nondrinkers, once or twice a week, three or four times a week, five or six times a week, and everyday drinkers.
Results:
Multivariable-adjusted [age, body mass index, hypertension, diabetes, hyper-low-density lipoprotein (LDL) cholesterolemia, smoking, and physical activity] odds ratios and 95% confidence intervals (CIs) were calculated using logistic regression analysis. Compared with the results for the nondrinkers, the multivariable-adjusted odds ratios of CKD were as follows: 0.76 (95% CI 0.60-0.95) for 1-2 drinks per week, 0.74 (95% CI 0.59-0.93) for 3-4 drinks per week, 0.79 (95% CI 0.64-0.97) for 5-6 drinks per week, and 0.60 (95% CI 0.51-0.71) for everyday drinkers. There was a significant inverse trend across increasing frequency of drinking alcohol (p = 0.001 for trend).
Conclusions:
An inverse association was found between frequency of drinking alcohol and CKD in apparently healthy men.
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Diabetic Nephropathy
Acute Kidney Injury III: Clinical Manifestations